Sale!

RNASET2 Gene Leukoencephalopathy cystic without megalencephaly Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The RNASET2 gene leukoencephalopathy cystic without megalencephaly is a rare genetic disorder characterized by changes in the white matter of the brain, specifically the development of cysts without an increase in brain size (megalencephaly). This condition can lead to a range of neurological symptoms and challenges. The genetic basis of this disorder involves mutations in the RNASET2 gene, which plays a role in various cellular processes including the response to viral infections and the regulation of inflammation.

To diagnose this condition, genetic testing is crucial. DNA Labs UAE offers a specific test for this purpose, aimed at detecting mutations in the RNASET2 gene that are associated with leukoencephalopathy cystic without megalencephaly. The test is comprehensive and designed to provide accurate results, which are essential for confirming the diagnosis and facilitating appropriate management and care for affected individuals.

The cost of the test is 4400 AED, reflecting the specialized nature of the testing and the expertise required to interpret the results. Conducted in a state-of-the-art laboratory by professionals experienced in genetic diagnostics, this test represents a crucial step for families seeking answers about this rare condition. By confirming the genetic basis of the disease, it also opens the door to genetic counseling and discussions about the risk of recurrence in future pregnancies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

RNASET2 Gene Leukoencephalopathy cystic without megalencephaly Genetic Test

Components: RNASET2 Gene Leukoencephalopathy cystic without megalencephaly Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for RNASET2 Gene Leukoencephalopathy, cystic without megalencephaly NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RNASET2 Gene Leukoencephalopathy, cystic without megalencephaly.

Test Details

RNASET2 gene leukoencephalopathy, cystic without megalencephaly is a rare genetic disorder characterized by the degeneration of white matter in the brain. This condition is caused by mutations in the RNASET2 gene, which provides instructions for producing an enzyme called ribonuclease T2. This enzyme is involved in the breakdown of RNA molecules.

A genetic test, such as Next-Generation Sequencing (NGS), can be used to identify mutations in the RNASET2 gene. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or even the entire genome. This test can help confirm a diagnosis of RNASET2 gene leukoencephalopathy and identify specific mutations in the gene.

The symptoms of RNASET2 gene leukoencephalopathy, cystic without megalencephaly typically begin in childhood or adolescence and may include progressive neurological problems such as difficulty walking, muscle weakness, loss of coordination, seizures, and cognitive impairment. Brain imaging studies may reveal cystic changes in the white matter of the brain.

Genetic testing can be beneficial for individuals with suspected or confirmed RNASET2 gene leukoencephalopathy, cystic without megalencephaly, as it can provide a definitive diagnosis, help predict the course of the disease, and inform genetic counseling for affected individuals and their families. It may also aid in the development of targeted treatments or interventions in the future.

Test Name RNASET2 Gene Leukoencephalopathy cystic without megalencephaly Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for RNASET2 Gene Leukoencephalopathy, cystic without megalencephaly NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with RNASET2 Gene Leukoencephalopathy, cystic without megalencephaly
Test Details

RNASET2 gene leukoencephalopathy, cystic without megalencephaly is a rare genetic disorder characterized by the degeneration of white matter in the brain. This condition is caused by mutations in the RNASET2 gene, which provides instructions for producing an enzyme called ribonuclease T2. This enzyme is involved in the breakdown of RNA molecules.

A genetic test, such as Next-Generation Sequencing (NGS), can be used to identify mutations in the RNASET2 gene. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or even the entire genome. This test can help confirm a diagnosis of RNASET2 gene leukoencephalopathy and identify specific mutations in the gene.

The symptoms of RNASET2 gene leukoencephalopathy, cystic without megalencephaly typically begin in childhood or adolescence and may include progressive neurological problems such as difficulty walking, muscle weakness, loss of coordination, seizures, and cognitive impairment. Brain imaging studies may reveal cystic changes in the white matter of the brain.

Genetic testing can be beneficial for individuals with suspected or confirmed RNASET2 gene leukoencephalopathy, cystic without megalencephaly, as it can provide a definitive diagnosis, help predict the course of the disease, and inform genetic counseling for affected individuals and their families. It may also aid in the development of targeted treatments or interventions in the future.